Wall Street Analysts Think Castle Biosciences (CSTL) Could Surge 51.52%: Read This Before Placing a Bet

Shares of Castle Biosciences, Inc. (CSTL) have gained 1.5% over the past four weeks to close the last trading session at $27.06, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $41 indicates a potential upside of 51.5%.The average comprises nine short-term price targets ranging from a low of $32 to a high of $50, with a standard deviation of $5.22. While the lowest estimate indi ...